| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 26.213 | 18.423 | 15.455 | 22.791 | - | - | - | 0 |
| Total Income - EUR | - | 0 | 46.565 | 10.150 | 19.817 | 27.318 | - | - | - | 0 |
| Total Expenses - EUR | - | 0 | 21.529 | 23.761 | 18.676 | 25.409 | - | - | - | 7.112 |
| Gross Profit/Loss - EUR | - | 0 | 25.036 | -13.610 | 1.141 | 1.909 | - | - | - | -7.112 |
| Net Profit/Loss - EUR | - | 0 | 24.719 | -13.795 | 731 | 1.909 | - | - | - | -7.112 |
| Employees | - | 0 | 1 | 1 | 0 | 0 | - | - | - | 0 |
Check the financial reports for the company - Bios Falmedi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 3.530 | 27.635 | 19.522 | 11.718 | - | - | - | 0 |
| Current Assets | - | 0 | 52.423 | 39.423 | 57.913 | 74.514 | - | - | - | 342 |
| Inventories | - | 0 | 34.745 | 18.786 | 25.377 | 21.154 | - | - | - | 0 |
| Receivables | - | 0 | 13.352 | 17.102 | 30.412 | 47.026 | - | - | - | 27 |
| Cash | - | 0 | 4.325 | 3.535 | 2.124 | 6.334 | - | - | - | 314 |
| Shareholders Funds | - | 0 | 30.658 | 16.301 | 16.716 | 27.612 | - | - | - | -24.247 |
| Social Capital | - | 0 | 44 | 43 | 42 | 41 | - | - | - | 40 |
| Debts | - | 0 | 25.295 | 50.757 | 60.719 | 58.620 | - | - | - | 24.588 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Bios Falmedi Srl